HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unsafe Levels Of Heavy Metals In Supplements Concern EU Authorities In Q3

Executive Summary

Dietary supplements containing unauthorized or unsafe substances, including heavy metals at excessive levels, were reported to the European Commission by national regulators on more than 40 occasions in the third quarter of 2023.

You may also be interested in...



EU Authorities Clamp Down On Unsafe Erectile Dysfunction Supplements In Q2

Dietary supplements containing unsafe or unauthorized substances, including a number marketed to enhance sexual performance, were reported to the European Commission by national regulators on more than 50 occasions in the second quarter of 2023.

Europe Continues Clampdown On Unauthorized CBD Supplements

Numerous European countries are continuing to crack down on the sale of unauthorized CBD food products on safety grounds, an analysis by HBW Insight reveals. Germany and Denmark are leading the way in submitting reports to Europe's Rapid Alert System for Food and Feed.

Bayer Extends Personalized Health Offering With At-Home Biological Age Test

Advancing personalized consumer innovation in healthy aging is the goal of a new partnership between Bayer and biological age test development firm Hurdle.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel